Status:
UNKNOWN
Efficacy of Adipose Derived Stromal Vascular Fraction in the Treatment of Keloids
Lead Sponsor:
Makerere University
Conditions:
Adipose Derived Stem Cells
Keloid
Eligibility:
All Genders
18-60 years
Phase:
PHASE2
Brief Summary
Keloids affect upto 16% of Africans causing significant cosmetic, functional and psychosocial distress. Available treatment options are associated with high recurrence and highly variable symptom reli...
Detailed Description
Background: Keloids are a disorder of wound healing characterized with excessive scar formation affecting upto 16% of Africans. These are often associated with functional and cosmetic disfigurement wi...
Eligibility Criteria
Inclusion
- Patients with a single keloid of 1-2cm3 as these have the highest response to any treatment administered.
Exclusion
- Previous intra-lesional steroid injection treatment in the last three months as the effects may still be ongoing
- Insufficient abdominal fat pad(depth) of 3cm
- Confirmed bleeding disorder
- Ongoing systemic illness
- Ulceration or local keloid infection
Key Trial Info
Start Date :
May 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2023
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04391621
Start Date
May 1 2021
End Date
December 31 2023
Last Update
June 18 2021
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Surgery, Makerere University College of Health Sciences
Kampala, Uganda
2
Kiruddu National Referral Hospital
Kampala, Uganda